1. Home
  2. ACCO vs TENX Comparison

ACCO vs TENX Comparison

Compare ACCO & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acco Brands Corporation

ACCO

Acco Brands Corporation

HOLD

Current Price

$3.83

Market Cap

361.7M

ML Signal

HOLD

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$12.12

Market Cap

317.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACCO
TENX
Founded
1893
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
361.7M
317.8M
IPO Year
2005
2001

Fundamental Metrics

Financial Performance
Metric
ACCO
TENX
Price
$3.83
$12.12
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$5.00
$29.67
AVG Volume (30 Days)
926.4K
629.9K
Earning Date
04-30-2026
05-15-2026
Dividend Yield
9.26%
N/A
EPS Growth
141.51
N/A
EPS
0.20
N/A
Revenue
$1,524,700,000.00
N/A
Revenue This Year
$3.10
N/A
Revenue Next Year
$0.89
N/A
P/E Ratio
$19.28
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.81
$5.34
52 Week High
$4.30
$18.38

Technical Indicators

Market Signals
Indicator
ACCO
TENX
Relative Strength Index (RSI) 57.54 44.63
Support Level $3.82 $10.83
Resistance Level $4.20 $14.15
Average True Range (ATR) 0.13 0.73
MACD -0.03 0.05
Stochastic Oscillator 29.96 48.36

Price Performance

Historical Comparison
ACCO
TENX

About ACCO Acco Brands Corporation

ACCO Brands Corp is a consumer, technology and business branded products company providing brands and product solutions used in schools, homes and at work. Its brands include At-A-Glance, Barrilito, Buro, Esselte, Five Star, Foroni, GBC, Hilroy, Kensington, Leitz, Mead, PowerA, Quartet, Rapid, Swingline and Tilibra. The Company's product categories include gaming and computer accessories, storage and organization, notebooks, shredding, laminating and binding machines, dry erase boards and do-it-yourself tools. The Company operates through two segments, Americas and International. Americas includes the U.S., Canada, Brazil, Mexico and Chile, and International includes EMEA, Australia, New Zealand and Asia. Its products are sold in the U.S., Europe, Australia, Canada, Brazil and Mexico.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

Share on Social Networks: